April 1, 2026 – As the new national medical insurance policies were officially implemented nationwide today, HFMED, a leading provider of operating room equipment and one-stop clinical solutions, promptly released a series of supporting measures to actively respond to the policy requirements, optimize the supply of medical equipment, and help medical institutions adapt to the new changes in outpatient coordination and reimbursement. This move not only demonstrates HFMED's sense of social responsibility as a medical device enterprise, but also further promotes the deep integration of its products with the national medical and health development strategy.
According to the new medical insurance policy, the outpatient reimbursement rate for cancer patients has been significantly increased, with the employee medical insurance reimbursement rate not less than 90% and the resident medical insurance reimbursement rate not less than 80%, and most deductibles have been cancelled. At the same time, designated pharmacies can now enjoy outpatient overall reimbursement with electronic prescriptions, and the reimbursement standards between hospitals and pharmacies have been fully unified, which has brought unprecedented development opportunities for the upgrading of medical equipment in primary medical institutions and outpatient departments. In response to this, HFMED has quickly adjusted its product layout and service system to closely align with the policy orientation.
It is reported that HFMED will focus on optimizing the cost-effectiveness of its core products such as surgical lighting equipment and digital operating tables, launching cost-effective product models suitable for primary medical institutions and outpatient departments, while ensuring that the product quality and performance meet the clinical needs. In addition, the company will cooperate with local medical institutions to carry out targeted technical training and after-sales support, help medical institutions improve the efficiency of equipment use, and ensure that patients can fully enjoy the policy dividends brought by the new medical insurance policy. At the same time, HFMED will further strengthen the research and development of intelligent and miniaturized operating room equipment to adapt to the development needs of outpatient diagnosis and treatment and primary medical services.
"The implementation of the new medical insurance policy is a major measure to promote the high-quality development of the medical and health industry, which is of great significance for improving the accessibility of medical services and reducing the medical burden of patients," said a senior representative of HFMED. "HFMED will always take responding to national policies and serving clinical needs as its responsibility, continuously optimize product and service systems, provide more high-quality and cost-effective medical equipment and solutions for global medical institutions, and make positive contributions to the improvement of national medical and health services." For more information about HFMED's supporting measures for the new medical insurance policy, please visit www.sh-huifeng.com.